Company / FCF Margin
INOVIO PHARMACEUTICALS, INC. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-48019.1%
FY2025
5-year range
-48019.1% / -2403.7%
FY2021-FY2025
Trend
-220.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -220% YoY in FY2025, a notable deviation from the 9-year average annual change of -207%.
Based on SEC 10-K filings.
-48019.1% in FY2025 with a 5-year CAGR of -47770.9%.
Declined from -12223.6% to -48019.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -45597.1pp
- 5-Year Change
- -47770.9pp
- 10-Year Change
- -
Key checks
Key Insights
- INOVIO PHARMACEUTICALS, INC.'s fcf margin has declined for 6 consecutive years.
- In FY2025, fcf margin decreased 220.4% year-over-year.
- Peak fcf margin was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -48019.1% | -220.4% |
| FY2024 | -14986.2% | -22.6% |
| FY2023 | -12223.6% | -404.7% |
| FY2022 | -2422.0% | -0.8% |
| FY2021 | -2403.7% | -868.7% |
| FY2020 | -248.1% | -42.5% |
| FY2019 | -174.1% | +5.7% |
| FY2018 | -184.6% | -392.2% |
| FY2017 | -37.5% | +87.4% |
| FY2016 | -298.4% | -158.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026